Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China Releases Q1 Economic Report On Pharmaceutical Industry

This article was originally published in PharmAsia News

Executive Summary

China's National Development and Reform Commission (NDRC) has released the Q1 2008 report on the economic progress of key industries. The economic profit of the pharmaceutical industry increased 18.6 percent compared to the same period last year. Chemical medicine output hit 783,000 tonnes while patented Chinese medicine reached 273,000 tonnes, with increases of 11.7 and 10.2 percent, respectively. In the first two months of this year, the pharmaceutical industry realized a profit of 9.41 billion yuan, 50.1 percent higher than the same period in 2007. NDRC forecasts that the growth in output and sales will continue to maintain a level of over 20 percent for this year. With the government's growing investment in health care and tighter industrial supervisory policies, observers are positive about the pharmaceutical industry's outlook. (Click here for more - Chinese Language)

Latest Headlines
See All
UsernamePublicRestriction

Register

SC068550

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel